Trial intelligence / Profile preview

Single-dose methylprednisolone for prevention of postoperative delirium in elderly hip fracture surgery

2014-002492-29Phase 4Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Jun 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative delirium (POD) and delirium comparing Single-dose methylprednisolone with Placebo (2 arms). Primary endpoints: Incidence of postoperative delirium and Severity of postoperative delirium. Started Jun 2014; status: completed.

02

Drugs

methylprednisolone
03

Conditions

postoperative delirium (POD)delirium

Beyond the preview

Go deeper on 2014-002492-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002492-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call